Allscripts (MDRX) Misses Q4 EPS by 1c, Offers Q1 and FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Allscripts announces fourth quarter 2019 results and outlook for 2020
March 2, 2020 4:01 PM ESTFourth quarter 2019 bookings of $312 million, up 6% year-over-year Extended Allscripts Managed Services Agreement with Northwell Health through 2026 Contract revenue backlog up $500 million to $4.4 billion as of the end of the fourth quarter
CHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and twelve months ended December 31, 2019.
Bookings(1) were $312 million in the fourth quarter of 2019. This result compares with $295 million in the fourth quarter of 2018. Contract revenue backlog totaled $4.4 billion as of December 31, 2019.
Fourth... More
